Efficacy and safety of aliskiren-based dual and triple combination therapies in US minority patients with stage 2 hypertension (Q46876777)

From Wikidata
Jump to navigation Jump to search
scientific article published in March 2011
edit
Language Label Description Also known as
English
Efficacy and safety of aliskiren-based dual and triple combination therapies in US minority patients with stage 2 hypertension
scientific article published in March 2011

    Statements

    Efficacy and safety of aliskiren-based dual and triple combination therapies in US minority patients with stage 2 hypertension (English)

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit